Ottawa Hospital Research Institute

Other

Pipeline Programs↗

Distinct drugs in development (Preclinical–Phase 3)

Indications↗

Distinct diseases across all programs

196

Clinical Trials↗

All sponsored trials (all statuses)

Pipeline

Pipeline Snapshot

By Phase

8 drugs in development

Phase 33

Phase 23

Phase 11

Preclinical3

By Therapeutic Area

top 4

Oncology

330%

Gastroenterology

220%

Cardiovascular

110%

Respiratory

110%

R&D Momentum

76/100

Pipeline Velocity

47/100

Trial Completion Rate

84/100

Pipeline Concentration

24/100

Pipeline Freshness

53/100

Strategic Signals

↗Active in Cardiovascular but thin pipeline — potential licensing opportunity

Activity

Recent Activity

Last 14 days

Sep 9, 2026

Recruiting

Active Cancer Patients Having Cancer Related Invasive Procedures or Surgery and Needing Perioperative Management of Anticoagulation Therapy (ACE-HIGH): A Prospective Management Cohort Study

Sep 9, 2026

Completed

Feasibility and Initial Clinical Impressions of Predictive Monitoring Integrated With the RACE Team

Earlier

Sep 5, 2026TrialImplementation of Donation Advisor, a Personalized Clinical Decision Support Tool for Improved Efficiency and Effectiveness of Deceased Organ Donation and Transplantation

Sep 3, 2026TrialCan Pre-operative Anemia be Timely Identified and Optimized in Patients Awaiting Primary Arthroplasty Surgery? A Randomized Clinical Trial

Sep 3, 2026TrialAccuracy in aChieving Optimum reconstrUction: Measured- vs. Navigation- Techniques in Hip Arthroplasty

Sep 1, 2026TrialRandomized, Double-Blinded, Placebo-Controlled Trial to Investigate the Role of Laparoscopic Transversus Abdominis Plane Block in Gastric Bypass Surgery (LapTAP Trial)

Aug 27, 2026TrialHyperbaric Oxygen Therapy for Perianal Fistulizing Crohn's Disease Not Responsive or Intolerant to Conventional Care: HYPNOTIC Pilot Study

Aug 8, 2026TrialImmunomodulatory Maintenance Therapy Post-Autologous Hematopoietic Stem Cell Transplantation for Prevention of Systemic Sclerosis Relapse: A Pilot Randomized Trial

1 more events

Aug 7, 2026TrialThe TOPGUN Trial: Threshold for Operative and Postoperative Hemoglobin Trigger for Red Blood Cell Transfusion

Details

Company Info

Company Overview

—

Mkt Cap

—

Revenue

—

Cash

Pipeline

Drug Pipeline

Indication

Preclinical

Phase 1

Phase 2

Phase 3

Approved

PhagePreclinical

Inflammatory Bowel Disease (IBD)

Oxygen Gas for InhalationPreclinical

Oncology

Hematologic Malignancies

CLIC-1901Phase 2

Hematologic Malignancy

Cold-stored platelet concentratePhase 2

Prostate Cancer

Lupron DepotPhase 3

Respiratory

Bronchopulmonary Dysplasia

Human PlasmaPhase 2

Unknown / Other

PenthranePhase 3

PenthranePreclinical

PenthranePhase 3

PenthranePreclinical

Periprosthetic Joint Infection

PhagePhase 1

Rivaroxaban

Full dose rivaroxabanPhase 3

Trauma

PenthranePreclinical

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)